MCID: URM002
MIFTS: 50

Uremia malady

Category: Nephrological diseases

Aliases & Classifications for Uremia

About this section

Aliases & Descriptions for Uremia:

Name: Uremia 11 49 38 13 67
 
Uremia of Renal Origin 11

Classifications:



External Ids:

Disease Ontology11 DOID:4676
ICD1029 N19
MeSH38 D014511

Summaries for Uremia

About this section
Wikipedia:70 Uremia can be translated as \"urea in the blood\". Urea is one of the primary components of urine. It... more...

MalaCards based summary: Uremia, also known as uremia of renal origin, is related to coronary artery disease and obesity, and has symptoms including extrarenal uremia and uremic pruritis. An important gene associated with Uremia is EPO (Erythropoietin), and among its related pathways are Vitamin D synthesis and Osteoblast Signaling. The drugs charcoal and activated charcoal powder have been mentioned in the context of this disorder. Affiliated tissues include kidney, testes and endothelial, and related mouse phenotypes are limbs/digits/tail and digestive/alimentary.

Related Diseases for Uremia

About this section

Diseases related to Uremia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 207)
idRelated DiseaseScoreTop Affiliating Genes
1coronary artery disease28.8APOC3, CRP, INS, LPL
2obesity28.2ALB, CRP, INS, LEP, LPL, RETN
3myocardial infarction27.9ALB, APOC3, CRP, INS, RETN, VWF
4vitiligo mental retardation facial dysmorphism uremia11.8
5nephronophthisis 1, juvenile10.9
6hemolytic-uremic syndrome10.8
7euthyroid sick syndrome10.8
8chronic fungal otitis externa10.7CRP, INS
9cataract 2510.6ALB, B2M
10atrophic vulva10.6ALB, CRP
11intestinal disaccharidase deficiency10.6ALB, CRP, EPO
12conjunctival vascular disease10.6ALB, EPO, INS
13cartilage disease10.6ALB, CRP, INS
14protozoal dysentery10.6ALB, CRP
15rumination disorder10.6ALB, EPO, INS
16oral cavity carcinoma in situ10.5ALB, CRP
17hypodermyiasis10.5ALB, CASR, SPP1
18weaver syndrome 110.5PTH, VDR
19testicular brenner tumor10.5ALB, CASR, PTH
20vesicoureteral reflux10.5ALB, B2M
21hypercalciuria, absorptive10.5CASR, VDR
22pancreatic vasoactive intestinal peptide producing tumor10.5ALB, B2M, INS
23chronic apical periodontitis10.5ALB, B2M, CRP
24thymus mucoepidermoid carcinoma10.5B2M, EPO, PTH
25vertebrobasilar insufficiency10.5CRP, SPP1, TNFRSF11B
26ischemic heart disease10.5ALB, CRP, VWF
27central pontine myelinolysis10.4ALB, B2M, EPO
28loeys-dietz syndrome10.4ALB, PTH, VDR
29atypical follicular adenoma10.4ALB, B2M, CRP
30mixed lacrimal gland cancer10.4ALB, CRP, VDR
31ulcerative blepharitis10.4ALB, CRP, VWF
32angina pectoris10.4ALB, CRP, VWF
33c1s deficiency10.4INS, LPL
34adams-oliver syndrome 510.4CRP, SPP1, VWF
35capillariasis10.4CASR, PTH, VDR
36sensory peripheral neuropathy10.4CASR, PTH, VDR
37craniosynostosis10.4ALB, CRP, EPO, INS
38angelucci's syndrome10.4CASR, PTH, VDR
39mild pre-eclampsia10.4CASR, PTH, VDR
40ceroid lipofuscinosis, neuronal, 610.4CRP, SPP1, VWF
41bacillary angiomatosis10.4PTH, TNFRSF11B, VDR
42astrakhan spotted fever10.4CASR, PTH, VDR
43pulpitis10.4ALB, B2M, VWF
44iron metabolism disease10.4CRP, INS, SPP1
45glioblastoma multiforme10.4ALB, B2M
46leukodystrophy10.4CASR, PTH, VDR
47hole retinal cyst10.3ALB, INS
48conjunctival disease10.3ALB, CRP, LPL
49bone deterioration disease10.3PTH, TNFRSF11B, VDR
50adult respiratory distress syndrome10.3CRP, INS, VWF

Graphical network of the top 20 diseases related to Uremia:



Diseases related to uremia

Symptoms for Uremia

About this section

UMLS symptoms related to Uremia:


extrarenal uremia, uremic pruritis

Drugs & Therapeutics for Uremia

About this section

Drugs for Uremia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 166)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HistamineapprovedPhase 4103475614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
2
Histamine PhosphateapprovedPhase 4103351-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
3
Pregabalinapproved, illicit, investigationalPhase 4355148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
4
FexofenadineapprovedPhase 46183799-24-03348
Synonyms:
159389-12-5
2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid
76815-58-2
83799-24-0
AC1L1FQB
Allegra
Allegra-D 12 Hour
Allegra-D 24 Hour
BRD-A73368467-003-02-8
BSPBio_003521
C06999
C32H39NO4
CHEBI:5050
CHEMBL914
CID3348
Carboxyterfenadine
D07958
DB00950
EU-0100488
F 9427
Fexofenadine
Fexofenadine (INN)
Fexofenadine [INN:BAN]
Fexofenadine hydrochloride
Fexofendine
HSDB 7486
KBio2_002449
 
KBio2_005017
KBio2_007585
KBio3_002742
KBioGR_000807
KBioSS_002456
L000869
LS-28827
Lopac0_000488
MDL 16455
MolPort-002-508-207
NCGC00015453-03
NCGC00015453-06
NCGC00092389-02
NCGC00092389-03
SPBio_001197
STK624102
STOCK6S-26154
Spectrum2_001179
Spectrum3_001921
Spectrum4_000204
Spectrum5_001474
Spectrum_001914
Telfast
Telfast (TN)
Terfenadine acid metabolite
Terfenadine carboxylate
Terfenadine-COOH
Terfenidine carboxylate, MDL 16455
UNII-E6582LOH6V
fexofenadine
5
Gabapentinapproved, investigationalPhase 428960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
6
MetforminapprovedPhase 41746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
7
GlipizideapprovedPhase 43829094-61-93478
Synonyms:
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
172964-66-8
29094-61-9
29094-66-4
30553_FLUKA
38777-27-4
AC-15789
AC1L1G0Z
AC1Q2OG0
Aldiab
Alphapharm Brand of Glipizide
BIDD:GT0476
BPBio1_000224
BRD-K12219985-001-04-8
BRN 0903495
BSPBio_000202
BSPBio_001349
Bio-0161
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
C21H27N5O4S
CAS-29094-61-9
CBiol_001788
CHEBI:239286
CHEMBL1073
CID3478
CP 28,720
CP 28720
CP-28,720
CP-28720
CPD000058455
D00335
D005913
DB01067
Digrin
Dipazide
EINECS 249-427-6
EU-0100621
G-117
G117_SIGMA
Glibenese
Glibenese Brand of Glipizide
Glibetin
Glican
Glide
Glidiab
Glidiazinamide
Glipid
Glipizida
Glipizida [INN-Spanish]
Glipizide (USP/INN)
Glipizide Extended-Release Tablets
Glipizide Kenfarma Brand
Glipizide [USAN:BAN:INN]
Glipizidum
Glipizidum [INN-Latin]
Gluco-Rite
Gluco-rite
Glucolip
Glucotrol
Glucotrol (TN)
Glucotrol XL
Glucotrol XL, Glucotrol, Glipizide
Glucozide
Glupitel
Glupizide
Glyde
Glydiazinamide
Glypidizine
 
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
I06-0186
I06-1985
IDI1_033819
K 4024
K-4024
K4024
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
KBioGR_000069
KBioSS_000069
KS-1068
Kenfarma Brand of Glipizide
LS-159679
Lacer Brand of Glipizide
Lilly Brand of Glipizide
Lopac-G-117
Lopac0_000621
MLS000069386
MLS001148176
Melizide
Metaglip
Mindiab
Minidab
Minidiab
Minodiab
MolPort-002-885-830
MolPort-003-666-685
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea
NCGC00015462-01
NCGC00015462-02
NCGC00015462-05
NCGC00015462-11
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
Napizide
Ozidia
Pfizer Brand 1 of Glipizide
Pfizer Brand 2 of Glipizide
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
Prestwick_242
S1715_Selelck
S1715_Selleck
SAM002564210
SMR000058455
SPBio_002141
STK631952
Samarium(III) ionophore I
Semiglynase
Sucrazide
TK 1320
TL8006447
UNII-X7WDT95N5C
ZINC00537795
glipizide
nchembio.128-comp32
8
LiraglutideapprovedPhase 4315204656-20-2
Synonyms:
204656-20-2
Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
C439759
Liraglutida
Liraglutida [INN-Spanish]
Liraglutide
Liraglutide [USAN:INN]
Liraglutide recombinant
Liraglutidum
Liraglutidum [INN-Latin]
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
 
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
NN 2211
NN-2211
NN2211
NNC 90-1170
N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide
N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide
UNII-839I73S42A
Victoza
nn 2211
nn2211
victoza
9
BenzocaineapprovedPhase 418921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
10
PamidronateapprovedPhase 44440391-99-94674
Synonyms:
(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID
(3-Amino-1-hydroxypropylidene)bisphosphonic acid
(3-Amino-1-hydroxypropylidene)diphosphonic acid
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid)
(3-amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate
1-hydroxy-3-aminopropane-1,1-diphosphonic acid
3-Amino-1-hydroxypropylidene-1,1-diphosphonate
40391-99-9
57248-88-1
57248-88-1 (di-hydrochloride salt)
AC1L1IP4
AHPrBP
AKOS003599275
APD
Acide pamidronique
Acide pamidronique [INN-French]
Acido pamidronico
Acido pamidronico [INN-Spanish]
Acidum pamidronicum
Acidum pamidronicum [INN-Latin]
Amidronate
Aminomux
Aredia
BIDD:GT0538
Bisphosphonate 6
C019248
C07395
C3H11NO7P2
 
CHEMBL834
CID4674
ChemDiv1_025240
D07281
DB00282
EINECS 254-905-2
HMS2090C13
HMS658L06
HSCI1_000312
I14-2407
LS-174826
MolPort-002-131-054
NCGC00159433-02
NCGC00159433-03
Novartis brand of pamidronate disodium salt
PAMIDRONATE DISODIUM
PAMIDRONIC ACID
Pamidronate Disodium
Pamidronic acid
Pamidronic acid (INN)
Pamidronic acid [INN:BAN]
Ribodroat
Ribodroat (TN)
STOCK1N-12562
UNII-OYY3447OMC
amino-1-hydroxypropane-1,1-diphosphonate
aminohydroxypropylidene diphosphonate
aminopropanehydroxydiphosphonate
pamidronate
pamidronate calcium
pamidronate monosodium
11
Folic Acidapproved, nutraceutical, vet_approvedPhase 4427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
12
Vitamin Capproved, nutraceuticalPhase 451450-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic Vitamin
Antiscorbic vitamin
Antiscorbutic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-Cee
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce Lent
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Caps Td
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-Caps Tc
Cetane-Caps Td
Cetane-caps TC
Cetane-caps TD
Cetebe
 
Cetemican
Cevalin
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic Acid
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina Askorbova
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic Acid
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic Acid
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
acide ascorbique
acidum ascorbicum
acidum ascorbinicum
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
ácido ascórbico
13tannic acidapproved, NutraceuticalPhase 41892
14
Vitamin Eapproved, nutraceutical, vet_approvedPhase 440659-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
15AnalgesicsPhase 4, Phase 311287
16Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27793
17Hormone AntagonistsPhase 4, Phase 212778
18HormonesPhase 4, Phase 213979
19Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 212767
20Histamine AntagonistsPhase 4946
21Histamine H1 AntagonistsPhase 4782
22Histamine H1 Antagonists, Non-SedatingPhase 4354
23Peripheral Nervous System AgentsPhase 4, Phase 322776
24Central Nervous System DepressantsPhase 412806
25Calcium, DietaryPhase 45525
26Anti-Anxiety AgentsPhase 41816
27AnticonvulsantsPhase 42620
28Anti-Allergic AgentsPhase 41490
29calcium channel blockersPhase 41940
30Psychotropic DrugsPhase 46279
31Neurotransmitter AgentsPhase 417734
32Tranquilizing AgentsPhase 44164
33Polymethyl MethacrylatePhase 442
34Vitamin B ComplexPhase 44229
35VitaminsPhase 4, Phase 25095
36MicronutrientsPhase 4, Phase 25802
37HematinicsPhase 41630
38Dialysis SolutionsPhase 4, Phase 3, Phase 2172
39IncretinsPhase 41537
40AntioxidantsPhase 4, Phase 1, Phase 22928
41Trace ElementsPhase 4, Phase 25802
42Hypoglycemic AgentsPhase 4, Phase 25733
43TocopherolsPhase 4406
44TocotrienolsPhase 4402
45Protective AgentsPhase 4, Phase 1, Phase 27190
46Vasodilator AgentsPhase 43438
47FolateNutraceuticalPhase 44279
48Folinic AcidNutraceuticalPhase 43150
49TocopherolNutraceuticalPhase 4406
50Vitamin B9NutraceuticalPhase 44279

Interventional clinical trials:

(show top 50)    (show all 94)
idNameStatusNCT IDPhase
1Probiotics Use in the Chronic Peritoneal Dialysis PatientsUnknown statusNCT01076426Phase 4
2Pregabalin for the Treatment of Uremic PruritusUnknown statusNCT01852318Phase 4
3Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular EventsCompletedNCT00317005Phase 4
4Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis PatientsCompletedNCT01356433Phase 4
5Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial KidneyCompletedNCT00442819Phase 4
6Oxidative Stress and Hemodialysis Access FailureCompletedNCT00410449Phase 4
7Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNCT00513630Phase 4
8Heat Disinfection of HD Water Treatment System in Hemodialysis PatientsCompletedNCT01138280Phase 4
9Hannover Dialysis Outcome StudyCompletedNCT00529139Phase 4
10Very Low Protein Diet or Dialysis in Uremic Elderly?CompletedNCT00388648Phase 4
11A Clinical Trial of IntensiVE DialysisCompletedNCT00649298Phase 4
12Osteopenia and Renal Osteodystrophy: Evaluation and ManagementCompletedNCT00108394Phase 4
13Liraglutide Treatment to Patients With Severe Renal InsufficiencyCompletedNCT01394341Phase 4
14STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFECompletedNCT00278057Phase 4
15Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUSRecruitingNCT02574403Phase 4
16Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and TreatmentEnrolling by invitationNCT02614898Phase 4
17Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)Unknown statusNCT01486485Phase 3
18The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia PatientsCompletedNCT02747979Phase 2, Phase 3
19Effects of Convective Therapies in Dialysis PatientsCompletedNCT01583309Phase 3
20Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)CompletedNCT01410916Phase 2, Phase 3
21Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeCompletedNCT00004465Phase 3
22Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHURecruitingNCT02205541Phase 3
23Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance HemodialysisNot yet recruitingNCT02976688Phase 2, Phase 3
24Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)Not yet recruitingNCT02949128Phase 3
25The Plasma Large-Volume Exchange RCTWithdrawnNCT01433003Phase 3
26Effect of SVF Derived MSC in DCD Renal TransplantationUnknown statusNCT02492490Phase 1, Phase 2
27Clonal Deletion on Living-Relative Donor Kidney TransplantationUnknown statusNCT01408797Phase 1, Phase 2
28Treatment of Uremic Pruritus by Olive-omega 3 OintmentUnknown statusNCT01447693Phase 1, Phase 2
29Safety and Efficacy of BMMNC in Patients With Chronic Renal FailureUnknown statusNCT01876017Phase 1, Phase 2
30The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)Unknown statusNCT01757431Phase 2
31Rituximab in Patients With Relapsed or Refractory TTP-HUSUnknown statusNCT00531089Phase 2
32L-Cysteine in Peritoneal DialysisCompletedNCT02050139Phase 2
33Clinical and Biochemical Effects of Multipass HemodialysisCompletedNCT01267760Phase 2
34Omega-3 Fatty Acid Administration in Dialysis PatientsCompletedNCT00655525Phase 2
35Vitamin D, Insulin Resistance and Inflammation in ESRDCompletedNCT00656032Phase 2
36Role of Turmeric on Oxidative Modulation in ESRD PatientsCompletedNCT01906840Phase 1, Phase 2
37Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport SyndromeCompletedNCT00309257Phase 2
38Sevelamer in Proteinuric CKDCompletedNCT01968759Phase 2
39A Study in Patients With End-Stage Renal DiseaseCompletedNCT01200290Phase 2
40An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeCompletedNCT01194973Phase 2
41An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic SyndromeCompletedNCT01193348Phase 2
42Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844844Phase 2
43Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844545Phase 2
44Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSCompletedNCT00844428Phase 2
45Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT00838513Phase 2
46Induction With SVF Derived MSC in Living-related Kidney TransplantationRecruitingNCT02492308Phase 1, Phase 2
47Complement Inhibition in aHUS Dialysis PatientsRecruitingNCT02464891Phase 2
48Modulation of Gut Microbiota in End-stage Renal DiseaseNot yet recruitingNCT02568891Phase 2
49Effect of BM-MSCs in DCD Kidney TransplantationNot yet recruitingNCT02561767Phase 1, Phase 2
50Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2

Search NIH Clinical Center for Uremia

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: uremia

Genetic Tests for Uremia

About this section

Anatomical Context for Uremia

About this section

MalaCards organs/tissues related to Uremia:

35
Kidney, Testes, Endothelial, Bone, Liver, Monocytes, Heart

Animal Models for Uremia or affiliated genes

About this section

MGI Mouse Phenotypes related to Uremia:

40 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053719.4AHSG, GHR, LEP, PTH, TNFRSF11B, VDR
2MP:00053819.2ALB, B2M, CASR, INS, LEP, VDR
3MP:00053679.0ALB, CASR, GHR, INS, LEP, SPP1
4MP:00053798.9ALB, B2M, CASR, GHR, INS, LEP
5MP:00107718.3B2M, CASR, EPO, GHR, INS, LEP
6MP:00053697.8AHSG, ALB, CASR, EPO, GHR, INS
7MP:00053877.7B2M, CASR, CRP, EPO, GHR, INS
8MP:00053707.7ALB, B2M, EPO, GHR, INS, LEP
9MP:00053977.6B2M, CASR, EPO, GHR, INS, LEP
10MP:00053847.6ALB, B2M, CASR, EPO, GHR, INS
11MP:00053857.5B2M, CRP, EPO, GHR, INS, LEP
12MP:00053907.5AHSG, CASR, GHR, INS, LEP, PTH
13MP:00053787.2AHSG, B2M, CASR, GHR, INS, LEP
14MP:00107686.8ALB, B2M, CASR, EPO, GHR, INS
15MP:00053765.6AHSG, ALB, B2M, CASR, CRP, EPO

Publications for Uremia

About this section

Articles related to Uremia:

(show top 50)    (show all 673)
idTitleAuthorsYear
1
DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation. (27018948)
2016
2
Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. (26988587)
2016
3
Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss. (25783847)
2015
4
The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction. (26550224)
2015
5
Genome-wide analysis of DNA 5-hmC in peripheral blood of uremia by hMeDIP-chip. (24697287)
2014
6
Comparison of AMG 416 and cinacalcet in rodent models of uremia. (24884838)
2014
7
NFI_B in the development of endothelial activation and damage in uremia: an in vitro approach. (22937042)
2012
8
Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. (22131233)
2012
9
SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. (23074332)
2012
10
Effects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia. (22322482)
2012
11
Simultaneous pancreas-kidney transplants are appropriate in insulin-treated candidates with uremia regardless of diabetes type. (21527647)
2011
12
Treatment of cardiovascular calcification in uremia. (21824104)
2011
13
Ultrastructural analysis of vascular calcifications in uremia. (20203159)
2010
14
Apparent diffusion coefficient map based on diffusion-weighted magnetic resonance imaging is useful in diagnosing the brainstem variant of reversible posterior leukoencephalopathy syndrome with uremia. (20499125)
2010
15
Platelet/Leukocyte activation, inflammation, and uremia. (19708994)
2009
16
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic. (19188910)
2009
17
Cardiovascular effects of uremia in apolipoprotein E-deficient mice. (19939336)
2009
18
Severe hemolytic uremia syndrome and antiphospholipid antibodies following bowel infection in the absence of major vascular occlusions: an example of MAPS? (19160952)
2008
19
Uremia-related vascular calcification: more than apatite deposition. (17149373)
2007
20
Acute chorea with bilateral basal ganglia lesions in diabetic uremia. (17598608)
2007
21
Vascular disease and atherosclerosis in uremia. (16050410)
2005
22
Effect of dietary creatine on skeletal muscle myosin heavy chain isoform expression in an animal model of uremia. (15122059)
2004
23
Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. (12579405)
2003
24
Oxidative stress in uremia. (14564195)
2003
25
Calpain is a mediator of myocardial injury in experimental uremia: is it activated by endogenous ouabain? (12694339)
2003
26
Genetics in secondary hyperparathyroidism of uremia]. (15775089)
2003
27
Acute uremia in rats: feeding sucrose overnight is preferable to starvation. (12071587)
2002
28
Coronary artery disease in uremia: Etiology, diagnosis, and therapy. (11737581)
2001
29
Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. (11380830)
2001
30
Signs of autonomic neuropathy in childhood uremia. (11198598)
2001
31
The role of middle molecules in uremia--preliminary report of an international survey of nephrologists and scientists. (11477752)
2001
32
Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? (11168979)
2001
33
Selection bias impacts outcome reports of uremia therapy. (10873894)
2000
34
Dietary therapy in uremia: the impact on nutrition and progressive renal failure. (10828760)
2000
35
Mass spectrometric monitoring of albumin in uremia. (11044246)
2000
36
Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. (9987064)
1999
37
Medical management of secondary hyperparathyroidism in uremia. (10372838)
1999
38
Management of bleeding with uremia and liver disease. (10468149)
1999
39
Acute movement disorders with bilateral basal ganglia lesions in uremia. (9827621)
1998
40
Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. (9637262)
1998
41
Effects of benazepril on insulin resistance and glucose tolerance in uremia. (9725782)
1998
42
The use of the artificial kidney in the treatment of uremia. 1952. (9854252)
1998
43
Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. (9439444)
1997
44
Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. (8957048)
1996
45
Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. (8377388)
1993
46
Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. (8425560)
1993
47
The circadian rhythm of erythropoietin in subjects with pre-terminal uremia. (1563123)
1992
48
Prurigo nodularis: as association with uremia. (7086057)
1982
49
The influence of uremia upon renal hypertension. (5438011)
1970
50
Uremia and disseminated platelet-cell (thrombocyte) thrombosis; report of a case due to malignant nephrosclerosis with acute pancreatitis. (14914218)
1952

Variations for Uremia

About this section

Expression for genes affiliated with Uremia

About this section
Search GEO for disease gene expression data for Uremia.

Pathways for genes affiliated with Uremia

About this section

GO Terms for genes affiliated with Uremia

About this section

Cellular components related to Uremia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1HFE-transferrin receptor complexGO:199071210.5B2M, TF
2platelet alpha granule lumenGO:003109310.2AHSG, ALB, VWF
3chylomicronGO:004262710.1APOC3, LPL
4secretory granule lumenGO:003477410.0INS, TF
5extracellular exosomeGO:00700626.3AHSG, ALB, APOC3, B2M, CRP, LPL
6extracellular spaceGO:00056154.6AHSG, ALB, APOC3, B2M, CRP, EPO
7extracellular regionGO:00055764.5AHSG, ALB, APOC3, B2M, CRP, EPO

Biological processes related to Uremia according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1cellular response to iron ionGO:007128110.4B2M, TF
2intestinal absorptionGO:005089210.4LEP, VDR
3positive regulation of tyrosine phosphorylation of Stat5 proteinGO:004252310.3EPO, GHR
4positive regulation of glycogen biosynthetic processGO:004572510.3INS, PTH
5negative regulation of lipid storageGO:001088810.2CRP, LEP
6positive regulation of insulin receptor signaling pathwayGO:004662810.2INS, LEP
7negative regulation of vasodilationGO:004590810.1CRP, INS
8retina homeostasisGO:000189510.0ALB, B2M, TF
9negative regulation of lipid catabolic processGO:00509959.8APOC3, INS
10response to nutrientGO:00075849.7ALB, EPO, LEP, TNFRSF11B
11negative regulation of feeding behaviorGO:20002529.7INS, RETN
12lipoprotein metabolic processGO:00421579.5ALB, APOC3, LPL
13positive regulation of MAPK cascadeGO:00434109.5INS, LEP, TNFRSF11B
14platelet degranulationGO:00025769.5AHSG, ALB, TF, VWF
15skeletal system developmentGO:00015019.5AHSG, PTH, TNFRSF11B, VDR
16cellular calcium ion homeostasisGO:00068749.5CASR, PTH, VDR
17acute-phase responseGO:00069539.4AHSG, CRP, EPO, INS
18response to drugGO:00424938.6APOC3, B2M, LPL, PTH, TNFRSF11B

Molecular functions related to Uremia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide hormone receptor bindingGO:005142810.3LEP, PTH
2hormone activityGO:00051798.3EPO, INS, LEP, PTH, RETN

Sources for Uremia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet